Is 1,4-Dimethanesulphonyloxybutane Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use 1,4-Dimethanesulphonyloxybutane? Is 1,4-Dimethanesulphonyloxybutane safe for nursing mother and child? Does 1,4-Dimethanesulphonyloxybutane extracts into breast milk? Does 1,4-Dimethanesulphonyloxybutane has any long term or short term side effects on infants? Can 1,4-Dimethanesulphonyloxybutane influence milk supply or can 1,4-Dimethanesulphonyloxybutane decrease milk supply in lactating mothers?
1,4-Dimethanesulphonyloxybutane lactation summary
- DrLact safety Score for 1,4-Dimethanesulphonyloxybutane is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of 1,4-Dimethanesulphonyloxybutane may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that 1,4-Dimethanesulphonyloxybutane may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using 1,4-Dimethanesulphonyloxybutane .
- Usage of 1,4-Dimethanesulphonyloxybutane is in contradiction to breastfeeding hence if it is must to use 1,4-Dimethanesulphonyloxybutane and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About 1,4-Dimethanesulphonyloxybutane usage in lactation
Drug is cleared from the body in 10 elimination half-lives. Resuming breastfeeding is likely safe after 24 hours of pumping-and-dumping.
Answer by DrLact: About 1,4-Dimethanesulphonyloxybutane usage in lactation
Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy.[1] It might be possible to breastfeed safely during intermittent therapy with an appropriate period of breastfeeding abstinence. Although minimal data are available to determine an appropriate period to withhold breastfeeding, the drug's terminal half-live of 2.5 hours suggests that withholding breastfeeding for at least 24 hours may be sufficient. Chemotherapy may adversely affect the normal microbiome and chemical makeup of breastmilk.[2] Women who receive chemotherapy during pregnancy are more likely to have difficulty nursing their infant.[3]
1,4-Dimethanesulphonyloxybutane Side Effects in Breastfeeding
1,4-Dimethanesulphonyloxybutane in a dosage of 4 mg/day for 5 weeks was taken for myeloid leukemia by one woman while breastfeeding. Weekly monitoring found no adverse effects on her infant's leukocyte count or hemoglobin.[3]
Alternate Drugs
Cyclophosphamide(Dangerous)
Busulfan(Dangerous)
Mercaptopurine(Safe)
Cetuximab(Unsafe)
Carboplatin(Dangerous)
Hydroxyurea(Low Risk)
Paclitaxel(Dangerous)
Etoposide(Dangerous)
Fluorouracil(Dangerous)
Doxorubicin(Dangerous)
Gemcitabine(Dangerous)
Alemtuzumab(Low Risk)
Nivolumab(Unsafe)
Rituximab(Low Risk)
Vinblastine(Dangerous)
Docetaxel(Dangerous)
Cyclophosphamide(Dangerous)
Bevacizumab(Low Risk)
Bleomycin(Dangerous)
Cisplatin(Unsafe)
Pazopanib(Unsafe)
Vinorelbine(Dangerous)
Trastuzumab(Unsafe)
Dacarbazine(Dangerous)
Busulfan(Dangerous)
Imatinib(Unsafe)
Thioguanine(Dangerous)
Cladribine(Dangerous)
Azelaic Acid(Safe)
Erlotinib(Unsafe)
Letrozole(Dangerous)
Dasatinib(Unsafe)
Exemestane(Dangerous)
Vincristine(Dangerous)
Nilotinib(Unsafe)
Tamoxifen(Dangerous)
Mitoxantrone(Dangerous)
Dactinomycin(Dangerous)
Ipilimumab(Unsafe)